CRANBURY, N.J.--(BUSINESS WIRE)--OncLive®, the leading digital provider of resources and information to oncology professionals, will host State of the Science Summit™: Renal Cell and Bladder Carcinoma on March 29 at the Hilton Boston/Dedham from 5:45 to 9:00 p.m. The program will be chaired by Toni Choueiri, M.D., and Adam Kibel, M.D.
This educational event will delve into recent scientific developments in the treatment and management of renal cell and bladder carcinoma. The experts will discuss pressing topics that include emerging approaches in adjuvant therapies in high-risk renal cell carcinoma, integrated immunotherapy and targeted therapy in advanced kidney cancer, updates on robotic surgery approaches in kidney and bladder cancers, integrated immunotherapy and chemotherapy in advanced bladder cancer, and side effect management from systemic therapy in kidney and bladder cancers.
Presenters for the program include:
- Lauren Harshman, M.D.
- Bradley McGregor, M.D.
- Guru Sonpavde, M.D.
- Xiao Wei, M.D.
State of the Science Summit™ is a premier conference series hosted by OncLive® that features medical experts from across the nation. Aiming to discuss current treatment options, each summit integrates academic and community-based physicians and health care professionals from across key disciplines that range from medical and surgical oncology to hematology.
Registration is free and open to all health care professionals, and food and beverages will be served. For more information and to register, visit www.onclive.com/meetings/soss or contact Allison Cooper at ACooper@curetoday.com.
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for MJH Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.